The Executive Director will lead the US launch of a rare disease therapy, drive brand strategy, align stakeholders, and build a high-performing team.

Lead safety surveillance, benefit-risk strategy, and lifecycle management for Ultragenyx products, ensuring compliance with pharmacovigilance regulations.

The Head of Biostatistics and Statistical Programming oversees statistical aspects of clinical trials, ensuring integrity and strategic planning in drug development. Responsibilities include leading teams, guiding analysis, mentoring, and collaborating across departments.